Expected Moves

Estimated Q3 2026 financial results assessing the extreme capital deficiency and any remaining shell value for ACUS. Evaluates a potential spike to $0.005 versus a drop to $0.0001.

Expected timeline for an update on corporate viability, asset liquidation, or a reverse merger. Maps a bounce to $0.002 against stagnation at $0.0001.

Estimated full-year 2026 earnings confirming final liquidity status. Weighs a flat outcome at $0.001 against remaining floored at $0.0001.